Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.56 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13852779 | 0.95 | PDK2 (0.49) | PDK2ESR1ESR2 | |
| SCHEMBL13852764 | 0.95 | PDK2 (0.49) | PDK2ESR1ESR2 | |
| SCHEMBL13852785 | 0.90 | PDK2 (0.53) | PDK2 | |
| SCHEMBL464576 | 0.90 | PDK2 (0.53) | PDK2 | |
| SCHEMBL464515 | 0.90 | PDK2 (0.53) | PDK2 | |
| SCHEMBL13852772 | 0.90 | PDK2 (0.53) | PDK2 | |
| SCHEMBL13852762 | 0.90 | PDK2 (0.53) | PDK2 | |
| SCHEMBL431657 | 0.88 | PDK2 (0.54) | PDK2ESR1ESR2AKR1C3AKR1C2 | |
| SCHEMBL464551 | 0.84 | PDK2 (0.47) | PDK2 | |
| SCHEMBL464577 | 0.84 | PDK2 (0.47) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841004-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120061657-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-15 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-8084937-B2 | Binaphthyl compound and organic light emitting element using the same | CANON KABUSHIKI KAISHA (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091252-A1 | BINAPHTHYL COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME | ALPL, MT-ND4L, LAGE3 | PDK2 2968/4885ESR1 343/4885ESR2 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.